People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Pharmaceuticals, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VYNE Therapeutics Inc. | — | Pharmaceuticals | Series C | $139.5M | $971.1M | 2022 |
| TrendKite Inc. | — | Other Technology | Series B | $55.1M | $508.6M | 2015 |
| Athliance Holdings, Inc. | — | Other Technology | Series A | $5.9M | $119.3M | 2021 |
| ACFP Acquisition Holding Company, LLC | — | Other | Seed | $4.0M | $74.4M | 2011 |
Anthony Bruno at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony Bruno on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Morgan Flager | 1 | 20 |
| Blair Garrou | 1 | 17 |
| Andrew Perlman | 1 | 15 |
| Alan Taetle | 1 | 10 |
| Jay Takefman | 1 | 4 |
| Edward Schnipper | 1 | 4 |
| Steven Basta | 1 | 3 |
| Sean Feeney | 1 | 3 |
| Albert L. Cha | 1 | 2 |
| James Larrick | 1 | 2 |
| Matthew Allison | 1 | 2 |
| Erik Huddleston | 1 | 2 |
| Ketan L. Patel | 1 | 2 |
| Steven L. Basta | 1 | 2 |
| Nicholas Castaldo | 1 | 2 |
| Elan Schultz | 1 | 2 |
| PATRICK LEPORE | 1 | 1 |
| IAIN STUART | 1 | 1 |
| MUTYA HARSCH | 1 | 1 |
| Henrik Falktoft | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.